GENTACIDIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gentacidin, and when can generic versions of Gentacidin launch?
Gentacidin is a drug marketed by Novartis and is included in two NDAs.
The generic ingredient in GENTACIDIN is gentamicin sulfate. There are fifteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gentacidin
A generic version of GENTACIDIN was approved as gentamicin sulfate by SANDOZ on December 31st, 1969.
Summary for GENTACIDIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Formulation / Manufacturing: | see details |
DailyMed Link: | GENTACIDIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for GENTACIDIN
US Patents and Regulatory Information for GENTACIDIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | GENTACIDIN | gentamicin sulfate | OINTMENT;OPHTHALMIC | 062501-001 | Jul 26, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | GENTACIDIN | gentamicin sulfate | SOLUTION/DROPS;OPHTHALMIC | 062480-001 | Mar 30, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |